$31.54
4.58% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US80706P1030
Symbol
SRRK
Sector
Industry

Scholar Rock Holding Corp. Stock price

$31.54
+1.73 5.80% 1M
+3.68 13.21% 6M
-11.68 27.02% YTD
+19.02 151.92% 1Y
+26.25 496.22% 3Y
+11.86 60.26% 5Y
+16.04 103.48% 10Y
Nasdaq, Closing price Tue, May 20 2025
+1.38 4.58%
ISIN
US80706P1030
Symbol
SRRK
Sector
Industry

Key metrics

Market capitalization $2.99b
Enterprise Value $2.69b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 9.58
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-270.73m
Free Cash Flow (TTM) Free Cash Flow $-230.19m
Cash position $364.38m
EPS (TTM) EPS $-2.65
P/E forward negative
P/S forward 422.50
EV/Sales forward 380.00
Short interest 32.06%
Show more

Is Scholar Rock Holding Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Scholar Rock Holding Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Scholar Rock Holding Corp. forecast:

9x Buy
100%

Analyst Opinions

9 Analysts have issued a Scholar Rock Holding Corp. forecast:

Buy
100%

Financial data from Scholar Rock Holding Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs 1.73 1.73
62% 62%
-
-1.73 -1.73
62% 62%
-
- Selling and Administrative Expenses 79 79
60% 60%
-
- Research and Development Expense 188 188
44% 44%
-
-269 -269
46% 46%
-
- Depreciation and Amortization 1.73 1.73
62% 62%
-
EBIT (Operating Income) EBIT -271 -271
43% 43%
-
Net Profit -264 -264
44% 44%
-

In millions USD.

Don't miss a Thing! We will send you all news about Scholar Rock Holding Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Scholar Rock Holding Corp. Stock News

Neutral
Business Wire
4 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today announced that the company granted inducement equity awards covering an aggregate of 105,700 shares of its common...
Neutral
Seeking Alpha
6 days ago
Scholar Rock Holding Corporation (NASDAQ:SRRK ) Q1 2025 Earnings Conference Call May 14, 2025 8:15 AM ET Company Participants Rushmie Nofsinger - VP, Corporate Affairs and IR David Hallal - CEO Akshay Vaishnaw - President of R&D Keith Woods - COO Vikas Sinha - CFO Conference Call Participants Allison Bratzel - Piper Sandler Michael Yee - Jefferies Tessa Romero - JPMorgan David Nierengarten - We...
Neutral
Business Wire
7 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today reported financial results and updates for the first quarter ended March 31, 2025. “Scholar Rock is at an inflection point as we...
More Scholar Rock Holding Corp. News

Company Profile

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.

Head office United States
CEO David Hallal
Employees 196
Founded 2012
Website www.scholarrock.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today